Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers-Reference-Cited by-同舟云学术

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers

Published:2003-05 Issue:3 Volume:97 Page:365-368
ISSN:0035-9203
Container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene
language:en
Short-container-title:Transactions of the Royal Society of Tropical Medicine and Hygiene

Author:

Kamil A.A.,Khalil E.A.G.,Musa A.M.,Modabber F.,Mukhtar M.M.,Ibrahim M.E.,Zijlstra E.E.,Sacks D.,Smith P.G.,Zicker F.,El-Hassan A.M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology

Link

http://academic.oup.com/trstmh/article-pdf/97/3/365/5468059/97-3-365.pdf

Reference28 articles.

1. New perspectives on a subclinical form of visceral leighmaniasis;Badaro;Journal of Infectious Diseases,1986

2. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers;Bahar;Clinics in Dermatology,1996

3. Immune responses in healthy volunteers vaccinated with killed leishmanial promatigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production;Castes;Vaccine,1994

4. Leishmaniasis: immunological and clinical aspects and vaccines in Venezuela;Convit;Clinics in Dermatology,1996

5. Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG;Dube;Parasitology,1998

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis;Molecular Therapy - Methods & Clinical Development;2024-09

2. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

3. A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis;2024-04-11

4. Vaccine Development for Human Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

5. Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?;Vaccines;2022-02-07